N,N-[2,5-O-DIBENZYL-GLUCARYL]-DI-[VALINYL-AMINOMETHANYL-PYRIDINE]

(2R,3R,4R,5R)-2,5-Bis(benzyloxy)-3,4-dihydroxy-N,N′-bis{(2S)-3-methyl-1-oxo-1-[(2-pyridinylmethyl)amino]-2-butanyl}hexandiamid

(2R,3R,4R,5R)-2,5-Bis(benzyloxy)-3,4-dihydroxy-N,N′-bis{(2S)-3-methyl-1-oxo-1-[(2-pyridinylmethyl)amino]-2-butanyl}hexanediamide

(2R,3R,4R,5R)-2,5-Bis(benzyloxy)-3,4-dihydroxy-N,N′-bis{(2S)-3-méthyl-1-oxo-1-[(2-pyridinylméthyl)amino]-2-butanyl}hexanediamide

N,N-[2,5-O-DIBENZYL-GLUCARYL]-DI-[VALINYL-AMINOMETHANYL-PYRIDINE]

2,5-Bis-benzyloxy-3,4-dihydroxy-hexanedioic acid, bis-({2-methyl-1-[(pyridin-2-ylmethyl)-carbamoyl]-propyl}-amide)

Dimer of Gag-Pol polyprotein [489-587]

Gag-Pol polyprotein

INHIBITOR MSA367

POL_HV1N5

symmetric/asymmetric inhibitor 9